[go: up one dir, main page]

NO972814D0 - Forlenget-frigjöring granulære preparater og fremgangsmåte for fremstilling derav - Google Patents

Forlenget-frigjöring granulære preparater og fremgangsmåte for fremstilling derav

Info

Publication number
NO972814D0
NO972814D0 NO972814A NO972814A NO972814D0 NO 972814 D0 NO972814 D0 NO 972814D0 NO 972814 A NO972814 A NO 972814A NO 972814 A NO972814 A NO 972814A NO 972814 D0 NO972814 D0 NO 972814D0
Authority
NO
Norway
Prior art keywords
granular preparations
sustained
release
release granular
extended
Prior art date
Application number
NO972814A
Other languages
English (en)
Other versions
NO972814L (no
NO320356B1 (no
Inventor
Niroaki Nakagami
Masazumi Kojima
Shinji Sagasaki
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO972814D0 publication Critical patent/NO972814D0/no
Publication of NO972814L publication Critical patent/NO972814L/no
Publication of NO320356B1 publication Critical patent/NO320356B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19972814A 1994-12-19 1997-06-18 Fremgangsmate for fremstilling av et matrikstype-medisinsk forlenget-frigjoring granulaert preparater NO320356B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31441494 1994-12-19
PCT/JP1995/002594 WO1996019200A1 (en) 1994-12-19 1995-12-18 Sustained-release granular preparation and process for producing the same

Publications (3)

Publication Number Publication Date
NO972814D0 true NO972814D0 (no) 1997-06-18
NO972814L NO972814L (no) 1997-08-18
NO320356B1 NO320356B1 (no) 2005-11-28

Family

ID=18053063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972814A NO320356B1 (no) 1994-12-19 1997-06-18 Fremgangsmate for fremstilling av et matrikstype-medisinsk forlenget-frigjoring granulaert preparater

Country Status (14)

Country Link
US (2) US5858411A (no)
EP (1) EP0797987B1 (no)
JP (1) JP3893439B2 (no)
KR (1) KR100424931B1 (no)
CN (1) CN1093758C (no)
AT (1) ATE251896T1 (no)
DE (1) DE69531957T2 (no)
DK (1) DK0797987T3 (no)
ES (1) ES2210321T3 (no)
FI (1) FI119720B (no)
NO (1) NO320356B1 (no)
PT (1) PT797987E (no)
TW (1) TW406022B (no)
WO (1) WO1996019200A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) * 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
EP0901786B1 (en) * 1997-08-11 2007-06-13 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailability
US6632455B2 (en) * 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
ATE254908T1 (de) 1998-09-30 2003-12-15 Basf Ag Verwendung von wasserlöslichen oder wasserdispergierbaren polyether-haltigen pfropfpolymerisaten als überzugsmittel, bindemittel und/oder filmbildender hilfsstoff in pharmazeutischen darreichungsformen
EP1970052A2 (en) * 1999-02-09 2008-09-17 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
US6316462B1 (en) * 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process
JP4310605B2 (ja) * 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US20090215898A1 (en) 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
JP5205053B2 (ja) * 2004-07-30 2013-06-05 フェリング ビー．ブイ． トラネキサム酸製剤
US20060275365A1 (en) * 2005-06-07 2006-12-07 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
US20070059359A1 (en) * 2005-06-07 2007-03-15 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
CN101253148B (zh) 2005-06-20 2013-01-02 克塞诺波特公司 凝血酸的酰氧基烷基氨基甲酸酯前药，合成和使用的方法
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
SI2001445T1 (sl) * 2006-03-16 2015-02-27 Euro-Celtique S.A. Farmacevtski sferoidi
MX2008010233A (es) * 2008-03-10 2009-11-10 Eurodrug Lab B V Composicion de liberacion modificada, que comprende doxofilina.
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
US20110184060A1 (en) * 2010-01-22 2011-07-28 Xenoport, Inc. Oral dosage forms having a high loading of a tranexamic acid prodrug
EP2540317A4 (en) * 2010-02-22 2014-04-16 Daiichi Sankyo Co Ltd SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION
GB201010083D0 (en) * 2010-06-16 2010-07-21 Univ Bradford Compositions and methods
KR102286952B1 (ko) * 2013-12-31 2021-08-09 롯데정밀화학 주식회사 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
RU2018145364A (ru) 2016-06-27 2020-07-28 Ачиллион Фармасьютикалс, Инк. Хиназолиновые и индольные соединения для лечения медицинских нарушений
EP3589628B1 (en) 2017-03-01 2025-05-07 Achillion Pharmaceuticals, Inc. Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
JP7538113B2 (ja) 2018-08-20 2024-08-21 アキリオン ファーマシューティカルズ，インコーポレーテッド 補体ｄ因子の医学的障害の治療のための医薬化合物
WO2020051532A2 (en) 2018-09-06 2020-03-12 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
EP4603484A2 (en) 2019-12-19 2025-08-20 Georgia State University Research Foundation, Inc. Compounds for the treatment of bacterial infections and potentiation of antibiotics
US20250197403A1 (en) 2020-02-20 2025-06-19 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
WO2022066774A1 (en) 2020-09-23 2022-03-31 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4329451A (en) * 1980-11-03 1982-05-11 The Dow Chemical Company Preparing an aqueous dispersion of colloidal size particles of a water-insoluble polysaccharide derivative
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
EP0421582A1 (en) * 1989-10-03 1991-04-10 Warner-Lambert Company Chewable spray dried spheroidal microcapsules and polymer coated microcapsules and method for preparing same
JPH03232814A (ja) * 1990-02-08 1991-10-16 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
JP2915590B2 (ja) * 1991-02-15 1999-07-05 第一製薬株式会社 マスクされた粒状物
CA2108575C (en) * 1991-04-16 2002-10-22 Kouichi Nakamichi Method of manufacturing solid dispersion
DE4244466C2 (de) * 1992-12-24 1995-02-23 Pharmatech Gmbh Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten

Also Published As

Publication number Publication date
EP0797987B1 (en) 2003-10-15
PT797987E (pt) 2004-02-27
TW406022B (en) 2000-09-21
NO972814L (no) 1997-08-18
EP0797987A1 (en) 1997-10-01
FI972622A0 (fi) 1997-06-18
KR100424931B1 (ko) 2004-07-05
CN1093758C (zh) 2002-11-06
ES2210321T3 (es) 2004-07-01
US5858411A (en) 1999-01-12
JP3893439B2 (ja) 2007-03-14
FI119720B (fi) 2009-02-27
DK0797987T3 (da) 2004-02-16
US6030644A (en) 2000-02-29
EP0797987A4 (en) 1998-09-09
DE69531957D1 (de) 2003-11-20
DE69531957T2 (de) 2004-08-12
FI972622L (fi) 1997-06-18
NO320356B1 (no) 2005-11-28
ATE251896T1 (de) 2003-11-15
CN1170357A (zh) 1998-01-14
WO1996019200A1 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
NO972814D0 (no) Forlenget-frigjöring granulære preparater og fremgangsmåte for fremstilling derav
MY109813A (en) Process of preparing large dimension emulsion polymer particles, polymer product and uses thereof
EP0361874A3 (en) Granules having core and their production
IE890343L (en) Ultrasonic contrast agents, process for their preparation and their use as diagnostic and therapeutic agents
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
NZ239802A (en) A superior tasting pharmaceutical composition having porous particles produced through in situ gas generation and a process for its production
DE69529917D1 (de) Vernetzte mikropartikel und ihre verwendung als arzneiträger
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
TW270085B (no)
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
HU903961D0 (en) Process for producing 11-beta-aryl-4-oestrenes and pharmaceutical preparatives containing these compounds
GR3015634T3 (en) Process for the preparation of micronised biodegradable particles.
MY115211A (en) Novel amino acid derivatives, their preparation and use
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
GEP20002329B (en) Isatinoxime Derivatives, Method for Their Preparation, Pharmaceutical Composition and Method for Treatment
EP0606930A3 (en) Process for preparation of polymer particles, process for preparation of toner particles and particles prepared according to these processes.
GR3015052T3 (en) Antibiotic GE 2270 factors A1, A2, A3 and H.
FR2631344B1 (fr) Procede de preparation de poudre fine d'acide hyaluronique ou d'hyaluronate de sodium et poudre fine ainsi obtenue
CA2207334A1 (en) Sustained-release granular preparations and production process thereof
FR2689876B1 (fr) Dispersions silico-acryliques, leur procédé d'obtention, leur application en stéréophotolithographie et procédé de préparation d'objets en résine.
HUT60509A (en) Process for producing monomer and 125 i-marked derivatives of t-butyloxycarbonyl-l-tyrosylpeptidoglycan
EP0480391A3 (en) Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
CS39189A2 (en) Method of tetrahydropyridine derivatives production
RU96101270A (ru) Способ лечения аллергодерматозов у детей

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees